Share on StockTwits

Luminex (NASDAQ:LMNX) announced its earnings results on Monday. The company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.10 by $0.10, reports. The company had revenue of $55.50 million for the quarter, compared to the consensus estimate of $55.90 million.

Luminex (NASDAQ:LMNX) traded down 0.96% during mid-day trading on Monday, hitting $17.57. 293,733 shares of the company’s stock traded hands. Luminex has a one year low of $15.74 and a one year high of $23.59. The stock’s 50-day moving average is $17.34 and its 200-day moving average is $18.01. The company has a market cap of $747.1 million and a P/E ratio of 48.47.

LMNX has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of Luminex in a research note on Wednesday, April 30th. They now have a $20.00 price target on the stock. Analysts at Leerink Swann raised their price target on shares of Luminex from $22.00 to $23.00 in a research note on Tuesday, April 29th. They now have an “outperform” rating on the stock. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $20.33.

Luminex Corporation (NASDAQ:LMNX)develops, manufactures and sells biological testing technologies and products with applications throughout the life sciences and diagnostics industries.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.